Ridgewood Investments LLC Collegium Pharmaceutical, Inc Transaction History
Ridgewood Investments LLC
- $213 Million
- Q1 2025
A detailed history of Ridgewood Investments LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Ridgewood Investments LLC holds 200 shares of COLL stock, worth $5,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$5,868
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
253Shares Held
37.1MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$170 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$88 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$77.4 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$65.9 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$47.9 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...